Source: Circulation | Posted 8 years ago
Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin
Tags:
Iron therapy, given to treat anaemia in combination with recombinant human erythropoietin (rhEPO) in patients with end-stage renal disease (ESRD), depresses immune function by inhibiting TNF-a production and increasing IL-4. It might also effect the risk of cardiac events.
The randomised clinical study, led by G
Comments